Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2010
Combination of rituximab (RTX) with several different chemotherapeutic regimes has proven synergistic effects in patients with either lymphoma or autoimmune diseases. First data of uncontrolled trials with the combination of RTX and leflunomide (LEF) are available.
Epistemonikos ID: edda92dd5d1e93c1756c8323d7c80769f42aa5eb
First added on: Mar 23, 2022